From THE DEPARTMENT OF MOLECULAR MEDICINE AND SURGERY Karolinska Institutet, Stockholm, Sweden THE HPA AXIS IN TYPE 2 DIABETES SOME ASPECTS IN RELATION TO INSULIN SENSITIVITY, BETA-CELL FUNCTION AND IGF-I/IGFBP-1

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study.

  2014cited by this paper
• Delta insulin-like growth factor binding protein-1 (ΔIGFBP-1): a marker of hepatic insulin resistance?

  2014cited by this paper
• The effect of physical activity on psychological distress, cortisol and obesity: results of the farming fit intervention program

  2013cited by this paper
• Mechanisms of Glucose Lowering of Dipeptidyl Peptidase-4 Inhibitor Sitagliptin When Used Alone or With Metformin in Type 2 Diabetes

  2013cited by this paper
• Transcriptional activation of melanocortin 2 receptor accessory protein by PPARγ in adipocytes.

  2013cited by this paper
• Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies

  2013cited by this paper
• Sitagliptin improves beta‐cell function in patients with acute coronary syndromes and newly diagnosed glucose abnormalities–the BEGAMI study

  2013cited by this paper
• Resistance training, visceral obesity and inflammatory response: a review of the evidence

  2012cited by this paper
• Stress hyperglycaemia in critically ill patients: potential role of incretin hormones; a preliminary study.

  2012cited by this paper
• Leptin and adiponectin: Distribution and associations with cardiovascular risk factors in men and women of the general population

  2012cited by this paper
• New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it.

  2012cited by this paper
• Associations between anthropometrical measurements, body composition, single‐nucleotide polymorphisms of the hypothalamus/pituitary/adrenal (HPA) axis and HPA axis functioning

  2011cited by this paper
• Energy, evolution, and human diseases: an overview.

  2011cited by this paper
• IGF-I Bioactivity in an Elderly Population

  2010cited by this paper
• Biological Basis of Depression in Adults with Diabetes

  2010cited by this paper
• Insulin Assay Standardization: Leading to Measures of Insulin Sensitivity and Secretion for Practical Clinical Care

  2010cited by this paper
• Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009

  2010cited by this paper
• Glucocorticoid regulation of preproglucagon transcription and RNA stability during stress

  2009cited by this paper
• Gender differences in corticotropin and corticosterone secretion and corticotropin-releasing factor mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats.

  2009cited by this paper
• Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men.

  2009cited by this paper
• Salivary cortisol differs with age and sex and shows inverse associations with WHR in Swedish women: a cross-sectional study

  2009cited by this paper
• Insulin-like Growth Factor-I (IGF-I) Serum Concentrations in Depressed Patients: Relationship to Saliva Cortisol and Changes during Antidepressant Treatment

  2009cited by this paper
• A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome.

  2009cited by this paper
• IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome.

  2009cited by this paper
• Stress and obesity: the role of the hypothalamic–pituitary–adrenal axis in metabolic disease

  2009cited by this paper
• Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity

  2008cited by this paper
• Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivity.

  2008cited by this paper
• Postprandial paradoxical IGFBP-1 response in obese patients with Type 2 diabetes.

  2008cited by this paper
• The relationship between smoking status and cortisol secretion.

  2007cited by this paper
• PPARgamma in human and mouse physiology.

  2007cited by this paper
• Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes.

  2007cited by this paper
• The effects of metformin and glibenclamide on glucose metabolism, counter‐regulatory hormones and cardiovascular responses in women with Type 2 diabetes during exercise of moderate intensity

  2007cited by this paper
• Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome.

  2007cited by this paper
• Long-Term Treatment of Central Cushing's Syndrome with Rosiglitazone

  2007cited by this paper
• Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.

  2007cited by this paper
• Effects of Pioglitazone on Suppressor of Cytokine Signaling 3 Expression

  2007cited by this paper
• Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism.

  2007cited by this paper
• Gender differences in hypothalamic-pituitary-adrenal (HPA) axis reactivity.

  2006cited by this paper
• Obesity, fat distribution and infertility.

  2006cited by this paper
• Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes

  2006cited by this paper
• Estradiol potentiates ghrelin-stimulated pulsatile growth hormone secretion in postmenopausal women.

  2006cited by this paper
• Sex Difference in the Relationship between the Hypothalamic‐pituitary‐adrenal Axis and Sex Hormones in Obesity

  2006cited by this paper
• Thiazolidinedione use and bone loss in older diabetic adults.

  2006cited by this paper
• The Insulin-like Growth Factor-binding Protein 1 Gene Is a Primary Target of Peroxisome Proliferator-activated Receptors*

  2006cited by this paper
• Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients.

  2005cited by this paper
• Structural and functional consequences of mitochondrial biogenesis in human adipocytes in vitro.

  2005cited by this paper
• Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome.

  2005cited by this paper
• Testosterone and estradiol regulate free insulin-like growth factor I (IGF-I), IGF binding protein 1 (IGFBP-1), and dimeric IGF-I/IGFBP-1 concentrations.

  2005cited by this paper
• Pre‐operative medical therapy with rosiglitazone in two patients with newly diagnosed pituitary‐dependent Cushing's syndrome

  2005cited by this paper
• Effects of Angiotensin Converting Enzyme Inhibition in Patients With Stable Coronary Artery Disease: The Prevention of Events With Angiotensin Converting Enzyme Inhibition (PEACE) Trial: The PEACE Study Investigators

  2005cited by this paper
• Gender differences in the relation of insulin‐like growth factor binding protein‐1 to cardiovascular risk factors: a population‐based study

  2005cited by this paper
• Approved IFCC recommendation on reporting results for blood glucose (abbreviated).

  2005cited by this paper
• Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease.

  2005cited by this paper
• Altered response of insulin-like growth factor-binding protein 1 to nutritional deprivation in type 2 diabetes mellitus.

  2005cited by this paper
• Global harmonization of hemoglobin A1c.

  2005cited by this paper
• Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance.

  2005cited by this paper
• Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke.

  2005cited by this paper
• Mechanism of the Anti-Inflammatory Effect of Thiazolidinediones: Relationship with the Glucocorticoid Pathway

  2005cited by this paper
• Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight.

  2005cited by this paper
• The impact of abnormalities in IGF and inflammatory systems on the metabolic syndrome.

  2004cited by this paper
• Enhanced circadian ACTH release in obese premenopausal women: reversal by short-term acipimox treatment.

  2004cited by this paper
• Aged transgenic mice with increased glucocorticoid sensitivity in pancreatic beta-cells develop diabetes.

  2004cited by this paper
• Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease.

  2004cited by this paper
• Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans.

  2004cited by this paper
• Nuclear receptor signaling and cardiac energetics.

  2004cited by this paper
• Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction.

  2004cited by this paper
• Cortisol and the metabolic syndrome in South Asians

  2003cited by this paper
• Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls.

  2003cited by this paper
• The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study.

  2003cited by this paper
• Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes.

  2003cited by this paper
• Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.

  2002cited by this paper
• Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.

  2002cited by this paper
• Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress.

  2002cited by this paper
• Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas.

  2002cited by this paper
• Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study.

  2002cited by this paper
• Glucocorticoid receptor variants: clinical implications.

  2002cited by this paper
• Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes.

  2002cited by this paper
• Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.

  2002cited by this paper
• High serum insulin-like growth factor binding protein-1 is associated with increased cardiovascular mortality in elderly men.

  2002cited by this paper
• IGF‐I in a normal population: relation to psychosocial factors

  2002cited by this paper
• Peroxisome proliferator activated receptors and obesity.

  2002cited by this paper
• Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study.

  2002cited by this paper
• The Pituitary Response to Ovine Corticotropin-Releasing Hormone is Enhanced in Obese Men and Correlates with Insulin Resistance

  2001cited by this paper
• Tissue-specific dysregulation of cortisol metabolism in human obesity.

  2001cited by this paper
• Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.

  2001cited by this paper
• Resistance to glucocorticoid feedback in obesity.

  2001cited by this paper
• Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients

  2001cited by this paper
• Subcutaneous continuous glucose monitoring: feasibility of a new microdialysis-based glucose sensor system.

  2001cited by this paper
• The insulin-like growth factor-I system and hormone replacement therapy.

  2001cited by this paper
• Molecular mechanism of insulin resistance in type 2 diabetes mellitus: role of the insulin receptor variant forms

  2001cited by this paper
• Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity.

  2001cited by this paper
• Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations

  2001cited by this paper
• Fat distribution in obese women is associated with subtle alterations of the hypothalamic–pituitary–adrenal axis activity and sensitivity to glucocorticoids

  2001cited by this paper
• Subclinical Cushing's syndrome.

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation.

  2000cited by this paper
• Secretin, glucagon, gastric inhibitory polypeptide, parathyroid hormone, and related peptides in the regulation of the hypothalamus- pituitary-adrenal axis.

  2000cited by this paper
• Low Plasma Insulin‐Like Growth Factor‐1 Concentrations Predict Worsening of Insulin‐Mediated Glucose Uptake in Older People

  1999cited by this paper
• Insulin Inhibits Growth Hormone Signaling via the Growth Hormone Receptor/JAK2/STAT5B Pathway*

  1999cited by this paper
• Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11beta-hydroxysteroid dehydrogenase type 1.

  1999cited by this paper

• Sex differences in type 2 diabetes: focus on disease course and outcomes

  2014cites this paper